7,8-Dihydro-2-methyl-1H-thiopyrano[4,3-d]pyrimidin-4(5H)-one, 95.0%, 5mg

4-(Dibromomethyl)-3-methoxybenzonitrile, 95.0%, 1g

Tapón de llave de paso, 12,5, 2,0 mm, 2 Pieza(s)

Ethyl 4-bromo-3-ethyl-1-methyl-1H-pyrazole-5-carboxylate, 95+%, 2g

4-Bromo-6-methylnicotinic acid, 98%, 1g

Nalpha-[(9H-Fluoren-9-ylmethoxy)carbonyl]-D-lysine Hydrochloride>98.0%(HPLC)1g

5-(1-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazol-2-amine, 95.0%, 1g

((2R,3R,4S,5R)-3-(Benzoyloxy)-5-bromo-4-fluorotetrahydrofuran-2-yl)methyl benzoate, 97%, 1g

(1S,3R)-1,2,2-Trimethylcyclopentane-1,3-dicarboxylic acid, 95.0%, 5g

4,4'-OXYDIBENZALDEHYDE, 95.0%, 1g

4,4'-Dimethoxybenzhydrol, 98.0%, 1g

2,2'-Bithiophene-5,5'-dicarboxaldehyde>98.0%(GC)5g

N-Isopropylmethacrylamide>98.0%(GC)25g